The search for knowledge: Developing the American Psychiatric Association's practice guideline for major depressive disorder

Journal of Clinical Psychiatry

Volumn 69, Issue 10, 2008, Pages 1658-1659

  Gelenberg, Alan J ^a  

^a Healthcare Technology Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

BRAIN DEPTH STIMULATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HEALTH CARE ORGANIZATION; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOTHERAPY; RECURRENT DISEASE; REMISSION; SHORT SURVEY; SUBSTANCE ABUSE; SUICIDE; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

EID: 54949122984     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n1016     Document Type: Short Survey

References (10)

1. American Psychiatric Association. Am J Psychiatry 1993 Apr; 150(suppl 4):1-26
2. American Psychiatric Association. Am J Psychiatry 2000 Apr; 157(suppl 4):1-45
3. Fochtmann LJ, Gelenberg AJ. Focus 2005;3:34-42
4. US Food and Drug Administration. http://www.fda.gov/cder/drug/ antidepressants/SSRIPHA200410.htm. Accessed August 15, 2008
5. Gibbons RD, Brown CH, Hur K, et al. Am J Psychiatry 2007 Sep;164(9):1356-1363
6. Katz LY, Kozyrskyj AL, Prior HJ, et al. CMAJ 2008 Apr;178(8):1005-1011
7. Trivedi MH, Rush AJ, Wisniewski SR, et al. Am J Psychiatry 2006 Jan;163(1):28-40
8. Keller MB, Trivedi MH, Thase ME, et al. J Clin Psychiatry 2007 Aug;68(8):1246-1256
9. Mischoulon D, Fava M. J Clin Psychiatry 2008;69:1496-1497
10. Geddes JR, Carney SM, Davies C, et al. Lancet 2003 Feb;361(9358):653-661